• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰系统性硬化症(SSc)的发病率和患病率——农村和城市地区的差异。

Incidence and prevalence of Systemic Sclerosis (SSc) in Poland - differences between rural and urban regions.

作者信息

Kanecki Krzysztof, Goryński Paweł, Tarka Patryk, Wierzba Waldemar, Tyszko Piotr

机构信息

Department of Social Medicine and Public Health, Medical University of Warsaw, Poland.

National Institute of Public Health - National Institute of Hygiene, Poland.

出版信息

Ann Agric Environ Med. 2017 May 11;24(2):240-244. doi: 10.5604/12321966.1233570.

DOI:10.5604/12321966.1233570
PMID:28664701
Abstract

UNLABELLED

[b] Abstract Introduction.[/b] Systemic sclerosis (SSc) is a rare and potentially severe connective tissue disease, characterized by skin fibrosis and involvement of internal organs. Because of its rarity and heterogeneous clinical presentation, reliable epidemiological studies on SSc have been particularly difficult to carry out. [b]Objectives[/b]. The purpose of this study was to present SSc epidemiology among hospitalized patients in Poland.

MATERIALS AND METHOD

The analysis was based on population-based administrative data, taken from a Polish hospital morbidity study carried out by the National Institute of Public Health between January 2008 - December 2012. [b]Results[/b]. Analyzed data covered 9,049 hospitalization records. The final sample comprised 3,653 patients with first-time hospitalizations for SSc. The average age of the sample was 53 years (SD 16.2; range 0-91 years); 84% of patients were female and 16% male. Based on hospitalization registers, the average SSc incidence was estimated to be 1.9/100,000 per year and peak age of incidence was 55 years. The point prevalence was estimated to be 9.4/100,000 at the end of 2012. SSc was more common in females, with F:M ratio ranging from 6.2:1-4.6:1 depending on the year. Analysis of hospitalization trends revealed that overall numbers of SSc hospitalizations increased, while first-time hospitalizations decreased between 2008-2012. Clusters of higher incidence were observed in more rural regions vs. urban regions. [b]Conclusion[/b]. Estimated incidence of SSc in Poland was comparable to reported incidence in other European countries. Analysis of demographic factors and reports of clusters of higher incidence may suggest the existence of environmental risk factors for the development of SSc. These observations may require further research.

摘要

未标注

[b]摘要 引言[/b]。系统性硬化症(SSc)是一种罕见且可能严重的结缔组织病,其特征为皮肤纤维化和内脏受累。由于其罕见性和临床表现的异质性,关于SSc的可靠流行病学研究一直特别难以开展。[b]目的[/b]。本研究的目的是呈现波兰住院患者中的SSc流行病学情况。

材料与方法

分析基于以人群为基础的行政数据,取自2008年1月至2012年12月期间由国家公共卫生研究所开展的一项波兰医院发病率研究。[b]结果[/b]。分析的数据涵盖9049份住院记录。最终样本包括3653例首次因SSc住院的患者。样本的平均年龄为53岁(标准差16.2;范围0 - 91岁);84%的患者为女性,16%为男性。根据住院登记册,SSc的平均发病率估计为每年1.9/10万,发病高峰年龄为55岁。2012年末的点患病率估计为9.4/10万。SSc在女性中更为常见,根据年份不同,女性与男性的比例在6.2:1至4.6:1之间。住院趋势分析显示,2008 - 2012年间,SSc住院的总体数量增加,而首次住院数量减少。在农村地区比城市地区观察到更高的发病率聚集区。[b]结论[/b]。波兰SSc的估计发病率与其他欧洲国家报告的发病率相当。对人口统计学因素和更高发病率聚集区报告的分析可能提示存在SSc发病的环境危险因素。这些观察结果可能需要进一步研究。

相似文献

1
Incidence and prevalence of Systemic Sclerosis (SSc) in Poland - differences between rural and urban regions.波兰系统性硬化症(SSc)的发病率和患病率——农村和城市地区的差异。
Ann Agric Environ Med. 2017 May 11;24(2):240-244. doi: 10.5604/12321966.1233570.
2
Takayasu's arteritis: a rare disease in Poland.高安动脉炎:波兰的一种罕见疾病。
Ann Agric Environ Med. 2018 Sep 25;25(3):469-472. doi: 10.26444/aaem/92702. Epub 2018 Sep 24.
3
Paget disease of bone among hospitalized patients in Poland.波兰住院患者中的骨佩吉特病
Ann Agric Environ Med. 2018 Mar 14;25(1):182-185. doi: 10.26444/aaem/81080. Epub 2018 Feb 12.
4
Geoepidemiology of systemic sclerosis.系统性硬化症的地理流行病学。
Autoimmun Rev. 2010 Mar;9(5):A311-8. doi: 10.1016/j.autrev.2009.11.003. Epub 2009 Nov 10.
5
Behçet disease: a rare systemic vasculitis in Poland.白塞病:波兰一种罕见的系统性血管炎。
Pol Arch Intern Med. 2017 Oct 31;127(10):652-656. doi: 10.20452/pamw.4091. Epub 2017 Aug 23.
6
Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.台湾系统性硬化症的流行病学和死亡率:一项全国性人群研究。
Scand J Rheumatol. 2011;40(5):373-8. doi: 10.3109/03009742.2011.553736. Epub 2011 Mar 9.
7
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.2001年至2012年期间,对西欧某地区系统性硬化症患者住院情况进行的基于人群的分析。
Rheumatol Int. 2016 Jan;36(1):73-81. doi: 10.1007/s00296-015-3330-1. Epub 2015 Jul 26.
8
Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health.2017-2020 年泰国系统性硬化症的发病率和患病率:来自公共卫生部的数据库。
Clin Rheumatol. 2023 Jul;42(7):1767-1774. doi: 10.1007/s10067-023-06550-7. Epub 2023 Mar 10.
9
Epidemiology of systemic sclerosis in a district of northern Italy.意大利北部一个地区系统性硬化症的流行病学。
Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S10-4. Epub 2011 May 12.
10
Contemporary epidemiology of systemic sclerosis: A population-based cohort study in the United Kingdom.当代系统性硬化症的流行病学:英国基于人群的队列研究。
Semin Arthritis Rheum. 2019 Aug;49(1):105-111. doi: 10.1016/j.semarthrit.2018.11.002. Epub 2018 Nov 10.

引用本文的文献

1
Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.全球系统性硬化症的发病率和患病率:一项全面的系统评价和荟萃分析。
Rheumatology (Oxford). 2021 Jul 1;60(7):3121-3133. doi: 10.1093/rheumatology/keab190.
2
Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL).肺动脉高压患者的特征:来自波兰肺动脉高压登记处(BNP-PL)的数据。
J Clin Med. 2020 Jan 8;9(1):173. doi: 10.3390/jcm9010173.
3
Positive effect of ozonotherapy on serum concentration of soluble interleukin-2 receptor and neopterin in patients with systemic sclerosis.
臭氧疗法对系统性硬化症患者血清可溶性白细胞介素-2受体和新蝶呤浓度的积极影响。
Postepy Dermatol Alergol. 2019 Apr;36(2):158-163. doi: 10.5114/ada.2019.83651. Epub 2019 May 14.
4
MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.微小 RNA-21 在皮肤纤维化中的作用:诊断和治疗的潜力。
Mol Diagn Ther. 2017 Dec;21(6):633-642. doi: 10.1007/s40291-017-0294-8.